Citigroup is set to report fourth-quarter earnings – here’s what the Street expects

FAN Editor

Jane Fraser, chief executive officer for Latin American at Citigroup Inc., speaks during the Milken Institute Global Conference in Beverly Hills, California, U.S., on Monday, April 29, 2019.

Kyle Grillot | Bloomberg via Getty Images

Citigroup is scheduled to report fourth-quarter earnings before the opening bell Friday.

Here’s what Wall Street expects:

  • Earnings: $1.34 a share, 38% lower than a year earlier, according to Refinitiv
  • Revenue: $16.7 billion, 9.1% lower than a year earlier
  • Net Interest Margin: 2.01%, according to FactSet
  • Trading Revenue: Fixed income: $2.61 billion, Equities: $697 million, according to FactSet

Citigroup made history when it announced Jane Fraser was taking over as CEO, making it the first big Wall Street bank to be run by a woman.

Now, weeks before she’s set to take over for Mike Corbat, Fraser is expected to address investors and analysts for the first time on Friday. Shareholders are keen to hear how Fraser, a former McKinsey partner who ran the bank’s Latin American operations before becoming president in 2019, will improve returns at the company.

Citigroup, the third-biggest U.S. bank by assets, has been hobbled by relatively poor performance compared to rivals including JPMorgan Chase, results that have frustrated investors including activist hedge fund ValueAct. The bank is also toiling under a regulatory consent order to improve its internal risk controls after it accidentally sent almost $900 million to lenders of Revlon last year.

Citigroup has said it expected fourth quarter trading revenues to climb 15% from a year earlier, while investment banking fees should climb by 10% to 15%.

Shares of the New York based bank fell 23% last year, compared to the 4.3% decline of the KBW Bank Index.

Free America Network Articles

Leave a Reply

Next Post

U.S. health officials push hospitals to administer unused Covid antibody drugs

The U.S. has shipped over half a million doses of antibody treatments that have the potential to keep high-risk Covid patients out of hospitals if given early enough in their infection. This would help already overburdened hospitals avoid additional strain, but the drugs are still being underutilized despite their promising […]

You May Like